41. MEdIC - Aplastic Anemia Answer Book Aplastic anemia is a rare but extremely serious disorder that results from the unexplained failure of the bone marrow to produce blood cells. http://medic.uth.tmc.edu/ptnt/00001038.htm

Aplastic Anemia Answer Book Aplastic Anemia - The Disease Aplastic anemia is a rare but extremely serious disorder that results from the unexplained failure of the bone marrow to produce blood cells. In all probability you had never heard of this disease until the time of diagnosis. We hope that this pamphlet helps you deal with your situation by providing basic information about aplastic anemia and the various treatment options. This pamphlet is not intended as a substitute for the advice of a physician. It is important that you ask questions and learn as much as you can about this disease. By contacting the Aplastic Anemia Foundation of America, you can be connected with others in your same situation and receive information free of charge. There are AAFA chapters around the country. You do not need to be alone in dealing with aplastic anemia. Normal Bone Marrow Function The central portion of bones is filled with a spongy red tissue called bone marrow. The bone marrow is essentially a factory producing the cells of the blood: red cells that carry oxygen from the lungs to all areas of the body, white cells that fight infection by attacking and destroying germs, and platelets that control bleeding by forming blood clots in areas of injury. Continuous production of blood cells is necessary all through life because each cell has a finite life span once it leaves the bone marrow and enters the blood: red cells120 days, platelets6 days, and white cellsone day or less!

42. Virtual Pediatric Hospital: CQQA: Anemia Common Questions, Quick Answers on anemia. anemia in children is most often caused by not eating enough iron, but can have other causes. http://www.virtualpediatrichospital.org/patients/cqqa/anemia.shtml

Home Search About Us FAQ ... Contact Us Pediatrics Common Questions, Quick Answers Anemia (Iron Deficiency) Donna D'Alessandro, M.D. Lindsay Huth, B.A. Peer Review Status: Internally Reviewed Creation Date: February 2002 Last Revision Date: April 2002 Common Questions, Quick Answers What is anemia? What causes anemia? Who can be anemic? ... When should I call the doctor? What is anemia? Anemia is having fewer red blood cells than is normal. Anemics do not have enough red blood cells. What causes anemia? The body uses iron to make red blood cells and to build muscle and strong bones. Red blood cells carry oxygen. Anemia in children is most often caused by not eating enough iron, but can have other causes. Heavy menstrual periods can cause anemia if too much iron is lost in the blood. Who can be anemic? Anyone who does not get enough iron can be anemic. It is especially important for infants and teens to get enough iron. Girls who are menstruating need lots of iron. What are the symptoms of anemia? There may be none. Symptoms are hard to notice unless the anemia is severe.

43. FDA Receives New Data On Risks Of Anemia Drugs Jan 3, 2008 The US Food and Drug Administration (FDA) is reviewing new data from two studies that provide further evidence of the risks of anemia drugs http://www.fda.gov/bbs/topics/NEWS/2008/NEW01769.html

FDA Home Page Search FDA Site FDA A-Z Index Contact FDA FDA News FOR IMMEDIATE RELEASE January 3, 2008 Media Inquiries: Karen Riley, 301-827-6244 Consumer Inquiries: 888-INFO-FDA FDA Receives New Data on Risks of Anemia Drugs Consistent With Previous Data on Tumor Growth and Death These two studies were not among the six studies that were described in revised labeling approved by FDA Nov. 8, 2007, which strengthened warnings about ESAs in cancer patients. Taken together, all eight studies show more rapid tumor growth or shortened survival when patients with breast, non-small cell lung, head and neck, lymphoid or cervical cancers received ESAs compared to patients who did not receive this treatment. In all of these recent studies, ESAs were administered in an attempt to achieve a hemoglobin level of 12 grams per deciliter (g/dL) or greater, although many patients did not reach that level. FDA plans to discuss this new data and revisit the risks and benefits of using ESAs in patients with chemotherapy-induced anemia at a public advisory committee meeting in the next few months. ESAs are a bioengineered version of a natural protein made in the kidney that stimulates the bone marrow to produce more red blood cells.

44. Anemia - Oncologychannel anemia is characterized by an insufficient number of red blood cells, which carry oxygen from the lungs to tissues throughout the body. http://www.oncologychannel.com/anemia/index.shtml

Home Search SiteMap Contact Us ... email this var addthis_pub = 'healthcommunities.com'; Stay Updated: Anemia Overview, Blood Transfusion, Other Treatment Physician developed and monitored. Original source: www.pulmonologychannel.com Original Date of Publication: 15 Nov 2003 Reviewed by: Stanley J. Swierzewski, III, M.D. Home Anemia Overview, Blood Transfusion, Other Treatment Questions to Ask Your Doctor About Your Cancer (Free Handout) Overview Anemia is characterized by an insufficient number of red blood cells (RBCs). RBCs carry oxygen from the lungs to tissues throughout the body. All cells require oxygen to function. Red blood cells originate in bone marrow as erythroblasts (a "blast" is a primitive cell that develops into a mature cell). Hemoglobin (Hb), a protein that binds to oxygen, is the main component of red blood cells. Once RBCs become filled with hemoglobin they enter the bloodstream as erythrocytes. Healthy hemoglobin holds the oxygen molecules with a precise degree of force. If it binds oxygen molecules in the lungs too loosely, it cannot hold onto them and carry them away. If it binds them too tightly, it cannot release them to tissues. Red blood cell production is stimulated by the hormone erythropoietin (EPO), which is produced in the kidneys. If the kidneys fail to produce adequate EPO, anemia develops.

45. Sickle Cell Anemia Disease Profile For more about the gene that causes sickle cell anemia, see the HBB Gene Profile. The following was adapted from NIH Publication No. 964057. http://www.ornl.gov/hgmis/posters/chromosome/sca.shtml

Human Genome Project Information Genomics:GTL DOE Microbial Genomics home The U.S. Department of Energy Biological and Environmental Research program funds this site. Genetic Disease Profile: Sickle Cell Anemia For more about the gene that causes sickle cell anemia, see the HBB Gene Profile . The following was adapted from NIH Publication No. 96-4057. Sickle Cell Timeline - Herrick provides the first formal description of sickle cell anemia when he reports that the blood smear of a dental student at the Chicago College of Dental Surgery contains "pear-shaped and elongated forms." - Hahn and Gillespie associate the sickling of red blood cells with low oxygen conditions. - Sherman reports that the sickling of red blood cells in the absence of oxygen is caused by a change in the hemoglobin molecule structure. - Watson suggests that the presence of fetal hemoglobin in the red blood cells of sickle cell newborns is the reason they do not show disease symptoms. - Noted physical chemist Linus Pauling and associates publish "Sickle Cell Anemia, a Molecular Disease" in

46. Anemia Many disease conditions are associated with thyroid diseases, but of all these diseases, the one with the highest association is anemia. http://www.ithyroid.com/anemia.htm

Anemia ANEMIA ANEMIATYPES AND CAUSES Many disease conditions are associated with thyroid diseases, but of all these diseases, the one with the highest association is anemia. I read one study which indicated that about one half of all hyperthyroids had clinically diagnosed anemia. It's possible, and to me quite likely, that the other half were also anemic but not diagnosed because they had copper-deficiency anemia and not iron-deficiency anemia. Anemia is usually caused by a deficiency of hemoglobin which is the oxygen carrying molecule in the red blood cell. While many minerals are important in the body's manufacture of hemoglobin, iron and copper are the most important. A deficiency of either iron or copper will result in anemia, either iron-deficiency anemia or copper-deficiency anemia. Anemia is often medically diagnosed by determining blood levels of iron and the iron-carrying protein ferritin. This test will determine anemia if the anemia is due to iron deficiency. However, this test will not show if the person has copper-deficiency anemia. It seems that many doctors are unaware of copper-deficiency anemia and will try to correct all cases of anemia by prescribing very large doses of iron. Since the majority of cases of anemia are probably the result of iron deficiency, then this procedure usually works. However, in copper-deficiency anemia, taking excess amounts of iron will further deplete copper and cause the anemia to worsen. This exact scenario has happened to more than one person in our group.

47. Anemia Answers to your questions about anemia and more! Information you can trust patient guides, the latest news, tips, tools, animations and newsletters. http://yourtotalhealth.ivillage.com/anemia.html

In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser. siteURL = "http://files.totalhealth.ivillage.com/ivth/files/ivth/animationfiles/flash_content/"; basefolder = "HCO"; BASEurl = siteURL + "BMCfile/" + basefolder + "/atlasvar.js"; popupURL = siteURL + "BMCfile/popupNF.js"; document.write(' '); document.write(' '); var pos5 = '0'; var pos6 = '1'; var pos7 = '1'; var pos8 = '0'; var pos9 = '0'; var pos10 = '0'; var pos11 = '1'; var pos13 = '1'; var yahooAd = '0'; var pos5 = parseInt(pos5) + 1; Main On TV iVillage YourTotalHealth Web powered by YAHOO! Home Health Centers Health A-Z Staying Healthy ... Heart Health var title='Anemia'; var id='com.nbc.ivillage.health.content.HealthGuideContentInstance@589d100d'; EMAIL TO FRIEND PRINTER FRIENDLY Aneurysm Arrhythmia Blood Clot Blood Pressure ... Women's Heart advertisement Anemia Summary About anemia About anemia and the heart Types and differences ... Questions for your doctor Reviewed By: Kerry Prewitt, M.D., FACC

48. The Rockefeller University - Fanconi Anemia Mutation Database The Fanconi anemia Mutation Database has been established as a cooperative effort in an effort to accelerate the availability of information. http://www.rockefeller.edu/fanconi/mutate/

FANCA FANCB FANCC FANCE FANCF FANCG FANCI FANCJ (BRIP1) FANCL FANCM FANCN (PALB2) Wednesday, May 28, 2008 Calendar Directory Job Opportunities Advanced Search ... Fanconi Anemia Mutation Database University Quick Links Research News Events Academics Hospital Resource Centers Giving Departments About Consortium Guidelines Related Sites Relevant Articles Home ... Printer-Friendly Version Fanconi Anemia Mutation Database The Fanconi Anemia Mutation Database was established in 1998 as a cooperative effort to accelerate the availability of information on mutations in these important cancer-predisposing genes. Although Fanconi anemia is a rare disorder with recessive inheritance, Fanconi anemia genes have been shown to play an important role in both birth defects and cancer. Update Notice Note that the display of data in the Fanconi Anemia Mutation Database has changed, as it is now using new software: L eiden O pen Source V ariation D atabase ( LOVD v.2.0). The new version of the site is open and accessible. Portions of the Fanconi anemia database are still under construction. We plan to add additional information on pathogenicity, population distribution and phenotypic associations, as in the HGVS Guidelines . In addition, we hope to form an

49. Meisha S Hope; A Guide To Canine Autoimmune Hemolytic Anemia A page of hope for owners, whose dogs suffer from canine autoimmune hemolytic anemia. http://www.cloudnet.com/~jdickson/

MEISHA'S HOPE A GUIDE to CANINE AUTOIMMUNE HEMOLYTIC ANEMIA AIHA/IMHA Race for Hope Meisha's Hope Treatment FAQ Meisha's Story A New Hope Success Stories tissue autopsy revealed she died amyloidosis probably caused by the long-standing AIHA. This site is dedicated to her and all the other dogs and their families who struggle with autoimmune hemolytic anemia. WHAT IS AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)? Lets define the terms of the disease one at a time. "Autoimmune" literally means the immunity against the self."Hemolytic" is the destruction of red blood cells. "Anemia" is a clinical sign, not a disease. Anemia is defined as a decrease in the number of red blood cells (RBC's) or the amount of hemoglobin, resulting in a decrease in the oxygen- carrying capacity of the blood. spherocyte occurs. Finding spherocytes on a blood smear almost guarantees that some form of hemolytic anemia is occurring. Since this disorder does not stop the production of red blood cells, there are usually immature red blood cells in the bloodstream which can be detected on the blood smears as well. WHAT ARE THE SYMPTOMS OF AUTOIMMUNE HEMOLYTIC ANEMIA?

50. NKF KDOQI Guidelines III Clinical Practice Recommendations for anemia in Chronic Kidney Disease in Children. 1.1. Identifying Patients and Initiating Evaluation; 1.2. http://www.kidney.org/professionals/KDOQI/guidelines_anemia/index.htm

NKF KDOQI GUIDELINES Published KDOQI Guidelines Are Available Online – click here. www.kdoqi.org KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease (2006) Tables Figures Abbreviations and Acronyms ... I: Executive Summary II: Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Adults Identifying Patients and Initiating Evaluation Evaluation of Anemia in CKD Hb Range Using ESAs Using Iron Agents Using Pharmacological and Nonpharmacological Adjuvants to ESA Treatment in HD-CKD Transfusion Therapy Evaluating and Correcting Persistent Failure To Reach or Maintain Intended Hb III: Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Children Identifying Patients and Initiating Evaluation Evaluation of Anemia in CKD Hb Range Using ESAs Using Iron Agents Using Pharmacological and Nonpharmacological Adjuvants to ESA Treatment in HD-CKD Transfusion Therapy Evaluating and Correcting Persistent Failure To Reach or Maintain Intended Hb Level IV: Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Transplant Recipients V: Appendix 1: Methods of Evidence Review and Synthesis Work Group Biographies Acknowledgments References © 2006 National Kidney Foundation, Inc.

51. ACS :: Anemia Drugs May Raise Risk Of Death In Cancer Patients Feb 27, 2008 Drugs used to boost red blood cell counts in cancer patients who become anemic may have some serious risks, new research suggests. http://www.cancer.org/docroot/NWS/content/NWS_1_1x_Anemia_Drugs_May_Raise_Risk_o

Home Community Get Involved Donate ... Site Index GetRandomImage("headerImage", "jpg", 121, 77, 30); My Planner Register Sign In Drugs used to boost red blood cell counts in cancer patients who become anemic may have some serious risks, new research suggests. ACS News Center Medical Updates News You Can Use Stories of Hope ... I Want to Help You can help in the fight against cancer. Donate and volunteer. It's easy and fun! Learn more Anemia Drugs May Raise Risk of Death in Cancer Patients Blood Clot Risk Also Higher Article date: Drugs prescribed to boost red blood cell counts in cancer patients who become anemic may actually be raising patients' risk of death, according to a new study led by researchers at Northwestern University's Feinberg School of Medicine. Cancer patients taking the drugs, known as erythropoiesis-stimulating agents or ESAs, were found to have a 10% higher chance of dying than patients who didn't take the drugs, the researchers found. In addition, they had a 57% higher risk of developing a potentially life-threatening blood clot. The study also suggests that ESAs may be fueling tumor growth, at least for some types of cancers. The findings are raising serious concerns about a class of drugs widely used and marketed to cancer patients.

52. Welcome To The DBA Foundation! OUR MISSION The mission of the Diamond Blackfan anemia Foundation, Inc. (DBAF) is to collectively and actively generate funds for the charitable and http://www.dbafoundation.org/

DBA Foundation Foundation Healthcare Professionals Research Families ... Current Issues OUR MISSION: The mission of the Diamond Blackfan Anemia Foundation, Inc. (DBAF) is "to collectively and actively generate funds for the charitable and scientific purpose of furthering, by clinical study, laboratory research, publication and teaching, the knowledge of the disorder known as Diamond Blackfan Anemia (DBA). Our intentions are to share this knowledge, to inform, to lend support, and to communicate with all families of DBA patients." OUR ORIGIN The DBAF was founded in 1994 by parents of children with Diamond Blackfan Anemia (DBA). The DBAF is a New York not-for-profit foundation registered with the Charities Bureau of New York State Department of Law, 120 Broadway, New York, New York 10271. THE DBAF TODAY: The DBAF supports itself solely through donations and is staffed exclusively by volunteers. The DBAF also funds medical research projects approved by its scientific advisory board. It organizes family meetings, publishes a semi-annual newsletter, and provides literature for those directly affected by DBA. ABOUT DBA: Diamond Blackfan anemia (DBA) is a rare red blood cell anemia usually diagnosed within the first two years of life. DBA patients are treated with steroids, usually prednisilone, and/or placed on a chronic red cell transfusion program. Bone marrow transplantation is only an option in very serious cases and when the patient has an HLA identical sibling match.

53. NEJM -- Severe Anemia In Malawian Children Original Article from The New England Journal of Medicine Severe anemia in Malawian Children. http://content.nejm.org/cgi/content/short/358/9/888

// var NTPT_PGEXTRA = ''; // var NTPT_PGREFTOP = false; // var NTPT_NOINITIALTAG = false; CM8ShowAd("Topbanner"); FREE NEJM E-TOC HOME SUBSCRIBE CURRENT ISSUE ... COLLECTIONS Search Term Advanced Search Sign in Subscribe Previous Volume 358:888-899 February 28, 2008 Number 9 Next Severe Anemia in Malawian Children Full Text PDF PDA Full Text PowerPoint Slide Set ... PubMed Citation ABSTRACT Background Severe anemia is a major cause of sickness and death in African children, yet the causes of anemia in this population have been inadequately studied. Methods g per deciliter) and 757 preschool children without severe anemia in urban and rural settings in Malawi. Causal factors previously associated with severe anemia were studied. The data were examined by multivariate analysis and structural equation modeling. Results Bacteremia (adjusted odds ratio, 5.3; 95% confidence interval [CI], 2.6 to 10.9), malaria (adjusted odds ratio, 2.3; 95% CI, 1.6 to 3.3), hookworm (adjusted odds ratio, 4.8; 95% CI, 2.0 to 11.8), human immunodeficiency virus infection (adjusted odds ratio, 2.0; 95% CI, 1.0 to 3.8), the

54. Anemia anemia is defined as lowering of red blood cells and disruption of their most important function carrying oxygen. In cancer patients, it may be mild to http://www.tirgan.com/anemia.htm

@import url(http://www.google.com/cse/api/branding.css); Custom Search by Tirgan.com Home Content services Types of Cancer ... SEARCH Anemia Anemia is defined as lowering of red blood cells and disruption of their most important function carrying oxygen. In cancer patients, it may be mild to severe and may be attributable to a variety of causes. Severity of anemia may increase as the disease progresses. Causes: Reduced production of blood from bone marrow, which is normally due to suppression of bone marrow by the cancer. Some cancers produce substances with a direct negative impact on the bone marrow; other cancers can spread and occupy the bone marrow space and interfere with blood production. In most instances, treatment of cancer also harms the bone marrow. Chemotherapy and Radiation therapy may both cause anemia. Bleeding may occur in cancer patients and result in anemia. Blood loss could be directly from the cancer site, as in colon cancer where bleeding occurs inside the large bowel. It may also be due to other causes. Cancer treatment can cause lowering of platelets which can make patients prone to bleeding. Most common sites for this kind of bleeding are the stomach and bowels, under the skin, gums, in the urine, etc.

55. FDA Panel Wants Restrictions On Anti Anemia Drugs Mar 10, 2008 The US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee decided yesterday to recommend restrictions on the use of anti http://www.medicalnewstoday.com/articles/100593.php

@import "/css/pagelayout.css"; @import "/css/default.css"; @import "/css/defaultnews.css"; Health News Health Videos Forum Advertise ... Contact News Archive [ link Web Wikipedia Medical Dictionary [ link Regulatory Affairs / Drug Approvals News Useful Links FDA Panel Wants Restrictions On Anti Anemia Drugs Featured Article Main Category: Regulatory Affairs / Drug Approvals Also Included In: Pharma Industry / Biotech Industry Cancer / Oncology Article Date: 14 Mar 2008 - 0:00 PDT email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: 5 (2 votes) Article Opinions: 1 posts The US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee decided yesterday to recommend restrictions on the use of anti anemia drugs to treat patients with certain types of cancer. The panel voted 13 to 1 in favour of keeping the drugs for use by many cancer patients, reported the New York Times. But it voted to recommend the drugs not be used to treat patients with breast cancer or head and neck cancer (the vote was 9 to 5 in favour of restriction). Head and neck cancers include those that affect the throat, sinuses and lymph nodes. And in a third vote, the committee recommended the drugs not be used in cases where the intention is to cure the patient's cancer (11 to 2, with 1 abstention). This generally refers to patients having chemotherapy following surgery for an early stage cancer, and where doctors believe there is a chance the cancer has been removed.

56. Iron Disorders Institute - Sideroblastic Anemia Sideroblastic anemia is an enzyme disorder in which the body has adequate iron but is unable to incorporate it into hemoglobin. Iron enters the developing http://www.irondisorders.org/Disorders/Sideroblastic.asp

Home FAQ Glossary of Terms Enter Keyword DISORDERS PUBLICATIONS IRON LIBRARY FOR PHYSICIANS ... ABOUT IDI Iron Imbalances Too Much Iron Too Little Iron Complicated Iron About Iron ... Back to Introduction Disorders of Iron Search by Disorder Hemochromatosis Acquired Iron Overload Sickle Cell Anemia Juvenile Hemochromatosis ... Anemia of Chronic Disease Iron Related Issues Iron and Genetics Treatment Options Sideroblastic Anemia S ideroblastic anemia is an enzyme disorder in which the body has adequate iron but is unable to incorporate it into hemoglobin. Iron enters the developing red blood cell (erythroblasts); here iron accumulates in the mitochondria giving a ringed appearance to the nucleus (ringed sideroblast). The mitochondria are overloaded with iron and hemoglobin production (heme synthesis) is defective. Sideroblasts are visible with Prussian blue staining and observable under microscopic examination of bone marrow. Because these ringed sideroblasts can develop poorly or not at all into mature red cells, anemia is the consequence. Sideroblastic anemia (SA) is a complicated disorder and therefore difficult to treat. . Often SA acts like iron deficiency anemia (IDA), but unlike IDA, iron tests are normal or increased with SA.

57. Anemia Complete info about Prezista (darunavir), a protease inhibitor treatment for HIV AIDS. http://www.atdn.org/simple/anemia.html

Anemia The Simple Facts Project is part of the AIDS Treatment Data Network. The Simple Facts Project does not promote, recommend nor endorse any treatment for any health related condition. If you need help finding out whether or not a specific drug or therapy is covered by private or public insurance, contact us. Toxicity to the bone marrow can cause the numbers of important blood cells to drop. A drop in the level of red blood cells can lead to a condition called anemia . Other blood cells that can be affected include bacteria-fighting white blood cells called neutrophils (a low level of these cells is called neutropenia). Less commonly, all blood cells can be affected and this condition is called pancytopenia. Symptoms: Symptoms of anemia can be tiredness, shortness of breath and dizziness. Neutropenia can lead to an increased risk of bacterial infection. Drugs responsible: zidovudine (AZT, Retrovir) is the most common cause of bone marrow toxicity. More rarely lamivudine (3TC, Epivir) has also been associated with neutropenia. Risk of experiencing this side effect: Diagnosis: Bone marrow suppression is diagnosed by testing blood cell levels on your regular blood work.

58. Wing-N-Wave Labradors Canine Autoimmune Hemolytic Anemia A disease characterized by increased destruction of red blood cells (erythrocytes) by the dog s own immune system, canine autoimmune hemolytic anemia (AIHA) http://www.labbies.com/aiha.htm

Home What's New About Wing-N-Wave Purchasing a Labrador ... Canine Legislature Pamela A. Davol, 76 Mildred Avenue, Swansea, MA 02777-1620 pdavol@labbies.com AIHA Letters A compilation of selected letters from my archives addressing issues pertaining to AIHA. Canine Autoimmune Hemolytic Anemia A disease characterized by increased destruction of red blood cells (erythrocytes) by the dog's own immune system, canine autoimmune hemolytic anemia (AIHA) is one of the most common blood (hematologic) disorders affecting canines. Though much attention has been given recently to AIHA due to evidence linking the process of vaccinating with the manifestation of this sometimes life-threatening disease, immunization is only one potential cause for this condition. The following article provides a detailed explanation of AIHA in terms of the disease process, diagnosis and treatment, and explores factors that may play a role in the development of this disorder in the canine. The Blood: A Brief Overview The blood is considered an organ having its own complex and diverse development, structure and functions. Its unique form, cellular tissue suspended in fluid plasma, allows it to serve as a main distribution system throughout the body. Cellular tissues composing the blood include: the red blood cells, which provide oxygen to tissues of the body; the white blood cells, which prevent invasion of microorganisms or other foreign substances; the lymphocytes, which carry out immune surveillance; and the platelets, which are involved in keeping the components of the blood in balance. Remarkably, all of these cellular components originate from a common source called stem cells located in the bone marrow. These stem cells give rise to a mature colony of cells which as they continue to divide and mature undergo a series of changes, a process known as differentiation, and eventually develop into the specialized blood cells indicated above.

59. Anemia (Low Hemoglobin) - DrGreene.com Alan Greene, MD, provides thorough answers to pediatric questions. Topics include bedwetting, ear infections, eating/nutrition, potty training, http://www.drgreene.com/21_1025.html

@import url(http://www.drgreene.org/default.css); ADVERTISEMENT Home DrGreene Content Chat with Dr. Greene Ask YOUR Question ... Find a Therapist DrGreene Content Anemia (Low hemoglobin) Introduction: Blood is a straw-colored liquid packed with red blood cells, white blood cells, and platelets (little clumps that help the blood clot when needed). The red blood cells carry oxygen from the lungs to every part of the body. They also give the blood its characteristic darkred color. This steady supply of oxygen to the body's tissues is necessary for health, for growth, and for life itself. What is it? When you don't have adequate red blood cells in your blood, you have anemia Normally about 1 percent of the red blood cells retire every day, to be replaced by about the same number of fresh, young red blood cells. Anemia occurs when the production of red blood cells is insufficient, when too many red blood cells are destroyed, or when blood is lost (through bleeding). Who gets it? There are many, many reasons a child might become anemic. The most common reason for a child to be anemic is an inadequate supply of iron.

60. Aplastic Anemia aplastic anemia myelodysplasia mds bone marrow transplant blood transfusion resource page. http://aplasticcentral.com/

Aplastic Anemia Home Bruce's BLOG ADD YOUR STORY (NEW) FREE Aplastic Book Preview ... Aplastic Patient Forum Web Site Start Here Latest AA News Old AA Forums Bone M ... start by clicking here. You will learn of the successes and failures of many Aplastic Anemia and MDS patients-some using conventional treatment protocols and others using alterative approaches. Judge for yourself what is working and take the time to learn everything you can about yourself, the illnesses and the approaches used to treat them. If you have questions, please visit the FORUM, an area where patients support patients or feel free to email me directly at bruce.lande@roadrunner.com We use this site to store everything we have learned about the autoimmune related illnesses including Aplastic Anemia Myelodysplastic Syndromes (MDS) and others. We also conduct an open, free spirited discussion on what is working and not working at the

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 80    Back | 1  | 2  | 3  | 4  | Next 20